Temozolamide-Based Chemo-Radiotherapy for High-Risk Low Grade Gliomas Reply

被引:0
|
作者
Fisher, Barbara J. [1 ]
机构
[1] Western Univ, Radiat Oncol, London, ON, Canada
关键词
D O I
10.1016/j.ijrobp.2020.05.057
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1118 / 1118
页数:1
相关论文
共 50 条
  • [41] DCIS classification into low or high-risk group by nuclear grade
    Yamagishi, Yoji
    Einama, Takahiro
    Kono, Takako
    Koiwai, Tomomi
    Tsuda, Hitoshi
    CANCER SCIENCE, 2018, 109 : 669 - 669
  • [42] Chemotherapy versus chemo-radiotherapy for high grade gastric non Hodgkin's lymphomas: Preliminary results of a randomized clinical trials.
    Martinelli, G
    Gomez, H
    Cortellazzo, S
    Ferrucci, PF
    Giordano, G
    Pruneri, G
    Crosta, C
    Orecchia, R
    Zucca, E
    BLOOD, 2003, 102 (11) : 403A - 404A
  • [43] MRI-based habitat imaging predicts high-risk molecular subtypes and early risk assessment of lower-grade gliomas
    Yang, Xiangli
    Niu, Wenju
    Wu, Kai
    Yang, Guoqiang
    Zhang, Hui
    CANCER IMAGING, 2025, 25 (01)
  • [44] Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study
    Jingjing Wang
    Lvjun Yan
    Ping Ai
    Yan He
    Hui Guan
    Zhigong Wei
    Ling He
    Xiaoli Mu
    Yanhui Liu
    Xingchen Peng
    Neurosurgical Review, 2021, 44 : 1447 - 1455
  • [45] Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study
    Wang, Jingjing
    Yan, Lvjun
    Ai, Ping
    He, Yan
    Guan, Hui
    Wei, Zhigong
    He, Ling
    Mu, Xiaoli
    Liu, Yanhui
    Peng, Xingchen
    NEUROSURGICAL REVIEW, 2021, 44 (03) : 1447 - 1455
  • [46] Cost Effectiveness of Radiation and Chemotherapy for High-Risk Low Grade Glioma
    Qian, Yushen
    Maruyama, Satoshi
    Kim, Haju
    Pollom, Erqi L.
    Kumar, Kiran A.
    Harris, Jeremy P.
    Chin, Alexander L.
    Pitt, Allison
    Bendavid, Eran
    Owens, Douglas K.
    Durkee, Ben Y.
    Soltys, Scott G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E26 - E26
  • [47] Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: results of the branch trial
    Avallone, Antonio
    Pecori, Biagio
    Bianco, Franco
    Aloj, Luigi
    Tatangelo, Fabiana
    Romano, Carmela
    Granata, Vincenza
    Marone, Pietro
    Leone, Alessandra
    Botti, Gerardo
    Petrillo, Antonella
    Caraco, Corradina
    Iaffaioli, Vincenzo R.
    Muto, Paolo
    Romano, Giovanni
    Comella, Pasquale
    Budillon, Alfredo
    Delrio, Paolo
    ONCOTARGET, 2015, 6 (30) : 30394 - 30407
  • [48] Strategies to maximize resection of complex, or high surgical risk, low-grade gliomas
    Wilden, Jessica A.
    Voorhies, Jason
    Mosier, Kristine M.
    O'Neill, Darren P.
    Cohen-Gadol, Aaron A.
    NEUROSURGICAL FOCUS, 2013, 34 (02)
  • [49] Analysis of histopathological and radiological parameters to predict response to radiotherapy in low- and high-grade gliomas
    Al-Haddad, S
    du Plessis, D
    Kopitzky, K
    Smith, T
    Husband, D
    Haylock, B
    Walker, C
    Warnke, P
    NEURO-ONCOLOGY, 2005, 7 (03) : 393 - 394
  • [50] Pediatric spinal cord gliomas-low grade but high risk for recurrence: should we treat them differently from intracranial low-grade gliomas?
    Sait, Sameer Farouk
    Karajannis, Matthias A.
    NEURO-ONCOLOGY, 2021, 23 (07) : 1046 - 1047